Author:
Wu Lichuan,Wang Guizhen,Liu Shuaibing,Wei Jinrui,Zhang Sen,Li Ming,Zhou Guangbiao,Wang Lisheng
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. McGuire, S. World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer. WHO Press, 2015. Adv Nutr 7, 418–419 (2016).
2. Herbst, R. S., Heymach, J. V. & Lippman, S. M. Lung cancer. N Engl J Med 359, 1367–1380 (2008).
3. Lynch, T. J. et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350, 2129–2139 (2004).
4. Paez, J. G. et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304, 1497–1500 (2004).
5. Guan, C. N., Cai, L. Z., Yue, L. Q. & Zhang, Y. Clinical study on treatment of advanced primary liver cancer by Yanshu injection combining with chemotherapy. Zhongguo Zhong Yao Za Zhi 31, 510–512 (2006).
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献